Objective: We have previously demonstrated that 1a, 25(OH) 2 D 3 promotes adipocyte reactive oxygen species (ROS) production. We have now evaluated whether decreasing 1a, 25(OH) 2 D 3 levels by increasing dietary calcium will decrease oxidative stress in vivo. Methods: We fed low-calcium (0.4% Ca) and high-calcium (1.2% Ca from CaCO 3 ) obesity-promoting (high sucrose/high fat) diets to aP2-agouti transgenic mice and assessed regulation of ROS production in adipose tissue and skeletal muscle. Results: Mice on the high-calcium diet gained 50% of the body weight (P ¼ 0.04) and fat (Po0.001) as mice on the low-calcium diet (0.4% Ca). The high-calcium diet significantly reduced adipose intracellular ROS production by 64 and 18% (Po0.001) and inhibited adipose tissue nicotinamide adenine dinucleotide phosphate oxidase expression by 49% (P ¼ 0.012) and 63% (P ¼ 0.05) in visceral and subcutaneous adipose tissue, respectively. Adipocyte intracellular calcium ([Ca 2 þ ]i) levels were suppressed in mice on the high-calcium diet by 73-80% (Po0.001). The high-calcium diet also induced 367 and 191% increases in adipose mitochondrial uncoupling protein 2 (UCP2) expression (Po0.001) in visceral and subcutaneous adipose tissue, respectively. The pattern of UCP3 expression and indices of ROS production in skeletal muscle were consistent with those in adipose tissue. The high-calcium diet also suppressed 11b-hydroxysteroid dehydrogenase (11b-HSD) expression in visceral adipose tissue by 39% (P ¼ 0.034). 11b-HSD expression was markedly higher in visceral vs subcutaneous adipose tissue in mice on the low-calcium diet (P ¼ 0.034), whereas no difference was observed between the fat depots in mice on the high-calcium diet. Conclusion: These data support a potential role for dietary calcium in the regulation of obesity-induced oxidative stress.
Introduction
Reactive oxygen species (ROS) production is increased in obesity and diabetes. [1] [2] [3] [4] It has been postulated that hyperglycemia and hyperlipidemia, key clinical manifestations of obesity and diabetes, may promote ROS production through multiple pathways. [5] [6] [7] Previous studies from this laboratory demonstrate an anti-obesity effect of dietary calcium, with increasing dietary calcium inhibiting lipogenesis, stimulating lipolysis and thermogenesis and increasing adipocyte apoptosis. [8] [9] These effects are mediated by suppression of 1a, 25-(OH) 2 D 3 -induced stimulation of Ca 2 þ influx and inhibition of adipocyte UCP2 gene expression. 10, 11 We have also recently shown that ROS production is modulated by mitochondrial uncoupling status and cytosol calcium signaling, and that 1a, 25(OH) 2 D 3 regulates ROS production in cultured murine and human adipocytes. 12 Accordingly, we propose that 1a, 25(OH) 2 D 3 may regulate oxidative stress in adipocytes by promoting ROS production, and that modulating 1a, 25(OH) 2 D 3 through dietary calcium may affect oxidative stress in vivo. Accordingly, we have now investigated the effect of dietary calcium on ROS production and the potential underlying mechanisms in adipose tissue and skeletal muscle in an animal obesity model. aP2-agouti transgenic mice were used as a model of obesityinduced oxidative stress. We previously described these mice as useful models for diet-induced obesity in a genetically susceptible human population in that they are not obese on a standard AIN-93 G diet, but develop mild to moderate obesity and hyperglycemia when fed high-sucrose and/or high-fat diets, 13, 14 indicating that aP2-agouti transgenic mice may be a potential animal model to study obesityassociated oxidative stress. Accordingly, before the dietary calcium experiments, we compared adipose ROS production between aP2 transgenic mice and wild-type mice following short-term exposure to the high-fat-high-sucrose diet in order to verify its suitability as an animal model.
Materials and methods
Animals and diets Animal pilot study. Six-week-old male aP2-agouti transgenic mice and wild-type male littermates (n ¼ 12/group) from our colony were utilized. Six mice randomly selected from each group were killed to provide baseline data and the remaining six mice in each group were put on a modified AIN 93 G diet 15 with sucrose as the sole carbohydrate source and providing 64% of energy, and fat increased to 25% of energy with lard as previously described. 13, 14 Mice were studied for 9 days, during which food intake and spillage were measured daily and body weight, fasting blood glucose and food consumption assessed weekly. At the conclusion of the study, all mice were killed under isofluorane anesthesia and fat pads were immediately excised, weighed and used for further study, as described below.
Diet study. At 6 weeks of age, 20 male aP2-agouti transgenic mice from our colony were randomly divided into two groups (10 mice/group) and fed a modified AIN 93 G diet with suboptimal calcium (calcium carbonate, 0.4%) or high calcium (calcium carbonate, 1.2%), respectively, with sucrose as the sole carbohydrate source and providing 64% of energy, and fat increased to 25% of energy with lard. Mice were studied for 3 weeks, during which food intake and spillage were measured daily and body weight, fasting blood glucose and food consumption assessed weekly. At the conclusion of the study, all mice were killed under isofluorane anesthesia and blood collected via cardiac puncture; visceral fat pads (perirenal and abdominal), subcutaneous fat pads (subscapular) and soleus muscle were immediately excised, weighed and used for further study, as described below. This study was approved from an ethical standpoint by the Institutional Care and Use Committee of The University of Tennessee.
Measurement of adipocyte intracellular Ca 2 þ
Adipose tissue was first washed several times with Hank's balanced salt solution (HBSS), minced into small pieces and digested with 0.8 mg/ml type I collagenase in a shaking water bath at 371C for 30 min. Adipocytes were then filtered through sterile 500-mm nylon mesh and cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 1% fetal bovine serum (FBS). Cells were cultured in suspension and maintained in a thin layer at the top of culture media for 2 h for cell recovery. Total RNA extraction A total cellular RNA isolation kit (Ambion, Austin, TX, USA) was used to extract total RNA from cells according to the manufacturer's instructions.
Quantitative real-time PCR Adipocyte 18s, UCP2, NADPH oxidase and 11b-HSD, and muscle UCP3 and NADPH oxidase were quantitatively measured using a Smart Cycler Real-Time PCR System (Cepheid, Sunnyvale, CA, USA) with a TaqMan 1000 Core Reagent Kit (Applied Biosystems, Branchburg, NJ, USA). The primers and probe sets were obtained from Applied Biosystems TaqMan s Assays-on-Demandt Gene Expression primers and probe set collection according to the manufacturer's instructions. Pooled adipocyte total RNA was serial-diluted in the range of 1.5625-25 ng and used to establish a standard curve; total RNAs for unknown samples were also diluted in this range. Reactions of quantitative RT-PCR for standards and unknown samples were also performed according to the instructions of Smart Cycler System (Cepheid, Sunnyvale, CA, USA) and using the Taqman RealTime PCR Core Kit (Applied Biosystems, Branchburg, NJ, USA). The mRNA quantitation for each sample was further normalized using the corresponding 18s quantitation.
Determination of intracellular reactive oxygen species generation
Adipose tissue digestion and adipocyte preparation were prepared as described in [Ca 2 þ ] i measurement. Intracellular ROS generation was assessed using 6-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate (H2-DCFDA) as described previously. 17 Cells were loaded with H2-DCFDA (2 mmol/l) for 30 min before the end of the incubation period (48 h). After washing twice with PBS, cells were scraped and disrupted by sonication on ice (20 s). Fluorescence (emission Dietary calcium regulates ROS production X Sun and MB Zemel 543 or 527 nm) and DNA content were then measured as described previously. The intensity of fluorescence was expressed as arbitrary units per ng DNA.
Statistical analysis
Data were evaluated for statistical significance by analysis of variance (ANOVA), and significantly different group means were then separated by the least significant difference test by using SPSS (SPSS Inc. Chicago, IL, USA). All data presented are expressed as mean7s.e.m.
Results
We first investigated whether aP2-agouti transgenic mice are also a suitable model for the study of diet-induced oxidative stress. Transgenic mice exhibited significantly greater baseline ROS production compared with wild-type controls before the feeding period, and the consumption of the obesity-promoting diet significantly increased adipose tissue ROS production only in aP2-agouti transgenic mice ( Figure 1a ). This effect was also associated with increased NADPH oxidase expression in adipose tissue of aP2-agouti transgenic mice before and following consumption of the obesity-promoting diet (Figure 1b) . We then utilized aP2 transgenic mice as a model to investigate the effect of dietary calcium on diet-induced oxidative stress in a 3-week study utilizing obesitypromoting (high-sucrose/high-fat) diets with either low calcium (0.4% from CaCO 3 ) (basal diet) or high calcium (1.2% from CaCO 3 ) (high-calcium diet) content. Although feeding high-fat/high-sucrose diets ad libitum for 3 weeks induced weight and fat gain in all animals, mice on the highcalcium diet gained only 50% of the body weight (P ¼ 0.04) and fat (Po0.001) of mice on the basal diet (Figure 2 ). Visceral body fat was disproportionately affected, with the sum of two visceral fat pad weights decreasing from 2.4870.19 g on the low-calcium diet to 1.3170.11 g on the high-calcium diet (Po0.002); when expressed as a percentage of body weight, the sum of the visceral fat pads decreased from 7.470.4 to 4.570.3% (Po0.001). There were no significant differences in daily food intakes between the low-calcium diet group and the high-calcium diet group (4.86 versus 4.77 g/day, P40.05). The high-calcium diet also suppressed diet-induced hyperglycemia and reduced fasting blood glucose by 15% compared to mice on the basal diet (P ¼ 0.003) (Figure 3) . The high-calcium diet significantly reduced adipose intracellular ROS production by 64 and 18% (Po0.001) in visceral and subcutaneous adipose tissue Dietary calcium regulates ROS production X Sun and MB Zemel basal diet ( Figure 5 ). Consistent with our previous study, 9 the high-calcium diet also induced 367 and 191% increases in adipose UCP2 expression (Po0.001) in visceral and subcutaneous adipose tissue, respectively, compared to mice on the basal diet (Figure 6a) . Moreover, the pattern of UCP3 expression and indices of ROS production in skeletal muscle was consistent with these findings. UCP3 expression was 22% higher (P ¼ 0.006) (Figure 6b ) and NADPH oxidase expression was 36% lower (P ¼ 0.001) (Figure 7 ) in soleus muscle of mice on the high-calcium diet compared to mice on the low-calcium diet. The high-calcium diet suppressed 11b-HSD expression in visceral adipose tissue by 39% (P ¼ 0.034) compared to mice on a basal diet (Figure 8 ). Interestingly, 11b-HSD expression in visceral fat was markedly higher than in subcutaneous fat in mice on basal low-calcium diet (P ¼ 0.034), whereas no difference was observed between the fat depots in mice on the high-calcium diet. Dietary calcium regulates ROS production X Sun and MB Zemel
Discussion
Data from the present study demonstrate that dietary calcium decreased diet-induced ROS production. Previous data from our laboratory demonstrate that dietary calcium exerts an anti-obesity effect via a 1a, 25-(OH) 2 -D 3 -mediated mechanism. 8 We have reported that 1a, 25-(OH) 2 -D 3 plays a direct role in the modulation of adipocyte Ca 2 þ signaling, resulting in an increased lipogenesis and decreased lipolysis. 18, 19 In addition, 1a, 25-(OH) 2 -D 3 also plays a role in regulating human adipocyte UCP2 expression, suggesting that the suppression of 1a, 25-(OH) 2 -D 3 and the resulting upregulation of UCP2 may contribute to increased rates of energy utilization. 10, 11 Accordingly, the suppression of 1a, 25-(OH) 2 -D 3 by increasing dietary calcium attenuates adipocyte triglyceride accumulation and caused a net reduction in fat mass in both mice and humans in the absence of caloric restriction, 13 a marked augmentation of body weight and fat loss during energy restriction in both mice and humans, 13, 20 and a reduction in the rate of weight and fat regain following energy restriction in mice. 14 Respiration is associated with production of ROS, and mitochondria produce a large fraction of the total ROS made in cells. 27 Mild uncoupling of respiration diminishes mitochondrial ROS formation by dissipating mitochondrial proton gradient and potential. 23 We also compared the ROS production between subcutaneous and visceral adipose tissue. Consistent with our previous data, 8, 29 animals on the basal low-calcium diet showed markedly higher visceral fat gain than subcutaneous fat versus mice on the high-calcium diet and exhibited enhanced ROS production and NADPH oxidase expression in visceral fat versus subcutaneous fat. Conversely, high dietary calcium attenuated visceral fat gain, and mice on the highcalcium diet exhibited similar ROS production in visceral and subcutaneous fat. These results indicate that higher visceral fat predisposes to enhanced ROS production. Accordingly, we further evaluated the involvement of autocrine glucocorticoids by measuring 11beta-hydroxysteroid dehydrogenase (11b-HSD) expression, the key enzyme responsible for converting glucocorticoid into its active form. 30 11b-HSD expression in visceral fat was markedly higher than in subcutaneous fat in mice on the basal lowcalcium diet, whereas no difference was observed between the fat depots in mice on the high-calcium diet. We also found that the high-calcium diet suppressed 11b-HSD expression in visceral adipose tissue compared to mice on the low-calcium diet. These findings demonstrate that dietary calcium exerts a greater effect on inhibition of visceral fat gain via suppressing active glucocorticoid production and may therefore explain the markedly decreased visceral fat gain in mice on the high-calcium diet compared with mice on the low-calcium diet. Therefore, the enhanced ROS production observed in visceral fat compared to subcutaneous fat only in mice on a low-calcium diet suggests that suppression of ROS production by dietary calcium may be mediated, in part, by the regulation of glucocorticoid-associated fat distribution. We recently reported that 1a, 25 (OH) 2 D 3 directly regulates adipocyte 11b-HSD 1 expression and local cortisol levels in cultured human adipocytes 31 by increasing both 11b-HSD 1 expression and cortisol release. Accordingly, suppression of 1a, 25 (OH) 2 D 3 via increasing dietary calcium may inhibit cortisol production in adipose tissue. Data from this study provide the first in vivo evidence that dietary calcium inhibits adipose tissue 11b-HSD expression and may thereby contribute to the preferential loss of visceral adiposity by regulating adipose tissue glucocorticoid production. Moreover, this decrease in visceral adiposity appears to contribute to reduced ROS production.
In conclusion, data from the present study support a role for dietary calcium in the regulation of diet-and obesity- 
